Skip to main content
Diseases

Mucinous Adenocarcinoma

mucinous adenocarcinoma

Entity Type
Diseases
Relation Groups
1
Relation Preview
8

Basic Information

Grouped by core information, identifiers, and descriptions.

Quick relations do not expand inferred candidates by default. Load path-derived ingredients or herbs when needed.

Core Information

Disease Name
Mucinous Adenocarcinoma
Standard Disease Name
mucinous adenocarcinoma
MeSH Tree
No data
ICD-10
No data

Identifiers

DO ID
No data
MeSH ID
D009444
OMIM ID
No data
UMLS ID
C0027814
HPO ID
No data

Description and Extensions

Description
MSH2017_2016_08_12:An experimental animal model for the demyelinating disease of GUILLAINE-BARRE SYNDROME. In the most frequently used protocol, animals are injected with a peripheral nerve tissue protein homogenate. After approximately 2 weeks the animals develop a neuropathy secondary to a T cell-mediated autoimmune response directed towards the MYELIN P2 PROTEIN in peripheral nerves. Pathologic findings include a perivascular accumulation of macrophages and T lymphocytes in the peripheral nervous system, similar to that seen in the Guillaine-Barre syndrome. (From Adams et al., Principles of Neurology, 6th ed, p1314; J Neuroimmunol 1998 Apr 1;84(1):40-52)
Related

Direct relations and traceable candidates grouped by relation type.

Related Targets

target disease8 Targets
01
BRAF
B-Raf proto-oncogene, serine/threonine kinase
B-Raf proto-oncogene, serine/threonine kinase